Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Short Interest Update

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totalling 900 shares, an increase of 80.0% from the December 31st total of 500 shares. Based on an average daily volume of 9,800 shares, the days-to-cover ratio is presently 0.1 days.

Relief Therapeutics Stock Performance

Shares of RLFTF stock traded up $0.08 during trading on Friday, reaching $4.06. 357 shares of the company’s stock traded hands, compared to its average volume of 4,408. Relief Therapeutics has a 1 year low of $1.10 and a 1 year high of $7.66. The firm’s 50-day moving average is $4.54 and its 200 day moving average is $3.92.

Relief Therapeutics Company Profile

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.